A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.

OBJECTIVE This study measured the annual rate of cognitive change in patients with Alzheimer's disease and determined the effects of clinical variables on that rate. It also compared the ability of two cognitive scales to measure change over the entire range of dementia severity. METHOD The cognitive subscale of the Alzheimer's Disease Assessment Scale and the Blessed test for information memory and concentration were given to 111 patients with Alzheimer's disease and 72 nondemented elderly comparison subjects at 6-month intervals for up to 90 months. Longitudinal changes in scores on the cognitive subscale were measured with several different methods of data analysis. RESULTS For the patients with Alzheimer's disease, the annual rate of change in cognitive subscale scores showed a quadratic relationship with dementia severity in which deterioration was slower for mildly and severely demented patients than for patients with moderate dementia. Gender, age at onset, and family history of dementia had no effect on the rate of cognitive deterioration. The comparison group showed a slight improvement in cognitive performance over time. All data analytic methods gave similar results. The cognitive subscale of the Alzheimer's Disease Assessment Scale was more sensitive to change in both mild and severe dementia than was the Blessed test. CONCLUSIONS These results suggest that cognitive deterioration is slow during the early and very late stages of Alzheimer's disease and more rapid during the middle stages. No clinical variables other than degree of cognitive impairment and previous rate of cognitive decline predicted rate of deterioration. These results have implications for treatment trials and attempts to identify subgroups.

[1]  K. Davis,et al.  Functional Decline in Alzheimer's Disease: A Longitudinal Study , 1993, Journal of the American Geriatrics Society.

[2]  R F Woolson,et al.  A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. , 1992, The New England journal of medicine.

[3]  K. Davis,et al.  Deterioration on the blessed test in Alzheimer's disease: Longitudinal data and their implications for clinical trials and identification of subtypes , 1992, Psychiatry Research.

[4]  Advanced Converter Task Force,et al.  Antidementia drug assessment symposium , 1991, Neurobiology of Aging.

[5]  L. Thal,et al.  Longitudinal evaluation of dementia of the Alzheimer type , 1990, Neurology.

[6]  Recommendations for Clinical Drug Trials in Dementia , 1990 .

[7]  G. van Belle,et al.  Reliability of estimates of changes in mental status test performance in senile dementia of the Alzheimer type. , 1990, Journal of clinical epidemiology.

[8]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[9]  H. Crystal,et al.  Rate of Progression of Alzheimer's Disease , 1989, Journal of the American Geriatrics Society.

[10]  J. Beyer,et al.  Familial risk of dementia associated with a biologic subtype of Alzheimer's disease. , 1988, Archives of general psychiatry.

[11]  L. Thal,et al.  Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease , 1988, Annals of neurology.

[12]  M. Grundman,et al.  Dementia: Characteristics of a referral population and factors associated with progression , 1988, Neurology.

[13]  K. Davis,et al.  Clinical predictors of course for Alzheimer patients in a longitudinal study: a preliminary report. , 1988, Psychopharmacology bulletin.

[14]  T J Rosen,et al.  Age at Onset and Rate of Progression of Alzheimer's Disease , 1987, Journal of the American Geriatrics Society.

[15]  Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. , 1986, The American journal of psychiatry.

[16]  K. Davis,et al.  A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.

[17]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[18]  D. Neary,et al.  Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease , 1983, Journal of neurochemistry.

[19]  V. Anderson,et al.  Dementia of the Alzheimer Type: Clinical Genetics, Natural History, and Associated Conditions , 1981 .

[20]  Jacob Cohen,et al.  Applied multiple regression/correlation analysis for the behavioral sciences , 1979 .

[21]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.